{"disease":{"id":"idiopathic-hypersomnia","name":"idiopathic hypersomnia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04827329","title":"Anesthetic Management of Patients With Chronic Sleep Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04330963","title":"International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05321355","title":"Mainz Register of Patients With Sleep Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Johannes Gutenberg University Mainz","has_results":false},{"nct_id":"NCT05156047","title":"A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Harmony Biosciences Management, Inc.","has_results":false},{"nct_id":"NCT05875974","title":"A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":false},{"nct_id":"NCT06457945","title":"Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03533114","title":"A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT05778721","title":"Psychiatric Co-morbidities and Socio-demographic Characteristics in Patients With Idiopathic Hypersomnia","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT05458128","title":"A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Harmony Biosciences Management, Inc.","has_results":false},{"nct_id":"NCT05615584","title":"Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence","phase":"NA","overall_status":"RECRUITING","enrollment_count":117,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06644573","title":"Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Nyree Penn","has_results":false},{"nct_id":"NCT06812078","title":"A Study of TAK-360 in Adults With Idiopathic Hypersomnia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07096674","title":"A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Centessa Pharmaceuticals (UK) Limited","has_results":false},{"nct_id":"NCT04026958","title":"Clarithromycin Mechanisms in Hypersomnia Syndromes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT03542851","title":"A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Balance Therapeutics","has_results":false},{"nct_id":"NCT06252571","title":"a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06590662","title":"Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06484348","title":"Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05668754","title":"Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Zevra Therapeutics","has_results":false},{"nct_id":"NCT03597555","title":"Sodium Oxybate in Idiopathic Hypersomnia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03772314","title":"Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT03356938","title":"The Role of the Circadian System in Neurological Sleep-wake Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Esther Werth","has_results":false},{"nct_id":"NCT03904238","title":"Psychosocial Adjunctive Treatment for Hypersomnia (PATH)","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04091438","title":"A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06251063","title":"Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Boston Children's Hospital","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}